If a drug has a much more well studied much more cheaper alternative on the market already, then for heavens sake run a head to head trial and show that the new drug is significantly better compared to its existing cousin. Otherwise even approval will not translate to sales. 7/

Hepatitis B/C can give cryoglobulinemia The immune activation, drops complement levels. The precipitation in the kidneys raises creatinine like collateral damage While waiting for cryoglobulin level, get a rheumatoid factor (RF). Cryoglobulin is an IgM against IgG. that IS a RF

Myxoinflammatory fibroblastic sarcoma, low-grade fibromyxoid sarcoma, low-grade myofibroblastic sarcoma, inflammatory myofibroblastic tumor, and myxofibrosarcoma walk into a room. #sarcoma #MedTwitter

Super start to CMRI Clinical Proteomics Symposium 2023 by Dr Amelia Parker on Extracellular matrix #proteomics in cancer 👏 Very interesting work! 👇 In #sarcoma- check out Paul Huang Lab Robin Lewis Jones paper on sarcoma #ECM

#Sarcoma specialist Robert Maki Sarcoma Service at Memorial Sloan Kettering did a very well received webinar on the latest #leiomyosarcoma research from #CTOS2023 for LMSDR.org. The link is: us02web.zoom.us/rec/share/EDdN… The passcode is: F7!&??5B

Keratin expression does not necessarily indicate carcinoma. Some sarcomas, such as this desmoplastic small round cell tumor (DSRCT), show extensive keratin immunoreactivity. Important to consider sarcomas in the differential diagnosis for keratin-positive tumors. #BSTpath

I’m in The Bronx and went to the deli to get some coffee & asked for oat milk or almond milk. The Spanish lady said, “Mami this is the Bronx, we don’t do that here. Go to Manhattan & get your oat milk.” 😭😭😂😂

Traditional Medicare or Medicare Advantage? The #Leukemia and Cancer Perspective doi.org/10.1016/j.mayo… Mayo Clinic Proceedings Hagop Kantarjian,MD MD Anderson Cancer Center Amer Zeidan MBBS,MHS ‏عامر زيدان Vincent Rajkumar #leusm

Just published a comprehensive review on the use of topoisomerase I inhibitors for treatment of sarcoma and their potential application as cytotoxic payload of novel, promising sarcoma-specific antibody/drug conjugates. Read doi.org/10.1159/000535…

Wow. I'm livid and shaking after the most aggressively obstructionist "peer to peer" auth appeal I've ever had. For a CT on a pt with an intracardiac sarcoma!!! #P2Phell #ourhealthcaresystemisfailingpatients #priorauth Carelon for @pacificsource - despicable practices.

A physician I know who served his community with all of his being recently retired after 30 years I saw that his name is no longer on the hospital website. There is barely an online trace that he ever worked there Think about that…

LMSDR has tips for people newly diagnosed with #leomyosarcoma: lmsdr.org/blog/top-tips-… #sarcoma #gyncsm

Candace Haddox, MD Dana-Farber

Clinical Trials update in #Desmoid : aacrjournals.org/clincancerres/…

Rare diseases add to our knowledge. 🧠 #RareDiseaseDay #RDDNIH

Rare Disease Day 2024 - February 29 | NORD. Individually rare, but altogether affects millions rarediseases.org/rare-disease-d…

#Sarcoma #EHE the trial is now out in Clinical Cancer Research aacrjournals.org/clincancerres/…

PEComa - to me one of the most enigmatic subtypes of soft tissue sarcoma: development of a new prognostic score discriminating between indolent and malignant variants. Read Gantzer et al. doi.org/10.1002/cncr.3…

HER2 is incredible target. Her2 IhC should be done on every cancer since Enhertu has tissue-agnostic approval My experience is that Enhertu works really well (including in pts with her2 1+ or 2+). But we dose reduce (prefer 2.7 mg/kg IV q3wks to start rather than 5.4 mg/kg)

In an ideal scenario the President of the United States and the worst person in the world would be two different people.